Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Rating of “Strong Sell” from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCRGet Free Report) have been assigned an average recommendation of “Strong Sell” from the nine brokerages that are covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $12.21.

OSCR has been the topic of a number of recent research reports. Barclays dropped their price target on Oscar Health from $17.00 to $11.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 23rd. Wall Street Zen downgraded shares of Oscar Health from a “buy” rating to a “hold” rating in a report on Sunday, June 8th. Raymond James Financial lowered shares of Oscar Health from an “outperform” rating to a “market perform” rating in a research report on Tuesday, June 24th. Baird R W lowered shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 25th. Finally, UBS Group reaffirmed a “sell” rating and issued a $11.00 price objective (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th.

Get Our Latest Stock Analysis on OSCR

Insider Buying and Selling

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director owned 64,512 shares of the company’s stock, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 24.39% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Southeastern Asset Management Inc. TN grew its stake in shares of Oscar Health by 52.2% in the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company’s stock worth $42,082,000 after purchasing an additional 1,073,359 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its stake in shares of Oscar Health by 37.8% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company’s stock valued at $23,403,000 after buying an additional 477,634 shares during the period. Man Group plc increased its position in Oscar Health by 344.8% during the 4th quarter. Man Group plc now owns 1,813,216 shares of the company’s stock valued at $24,370,000 after purchasing an additional 1,405,554 shares during the period. Victory Capital Management Inc. increased its position in shares of Oscar Health by 23.8% during the first quarter. Victory Capital Management Inc. now owns 285,997 shares of the company’s stock valued at $3,749,000 after buying an additional 54,938 shares during the period. Finally, Toronto Dominion Bank bought a new stake in Oscar Health during the 4th quarter valued at approximately $1,008,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Stock Performance

Shares of OSCR opened at $14.00 on Thursday. The stock has a 50 day moving average of $15.88 and a 200 day moving average of $14.91. The company has a market capitalization of $3.57 billion, a price-to-earnings ratio of 50.00 and a beta of 1.90. Oscar Health has a 12 month low of $11.20 and a 12 month high of $23.79. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22.

Oscar Health (NYSE:OSCRGet Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The firm’s quarterly revenue was up 42.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.62 earnings per share. As a group, sell-side analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

About Oscar Health

(Get Free Report

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Articles

Analyst Recommendations for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.